The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Vor Biopharma Inc shares valued at $688,853 were sold by Reprogrammed Interchange LLC on Sep 16 ’25. At $1.54 per share, Reprogrammed Interchange LLC sold 447,278 shares. The insider’s holdings dropped to 32,781,209 shares worth approximately $1.14 billion following the completion of this transaction.
Also, Reprogrammed Interchange LLC sold 400,000 shares, netting a total of over 656,320 in proceeds. Following the sale of shares at $1.64 each, the insider now holds 33,228,487 shares.
Before that, Reprogrammed Interchange LLC had sold 300,000 shares from its account. In a trade valued at $526,230, the 10% Owner traded Vor Biopharma Inc shares for $1.75 each. Upon closing the transaction, the insider’s holdings decreased to 300,000 shares, worth approximately $1.17 billion.
As published in a research note from Stifel on September 24, 2025, Vor Biopharma Inc [VOR] has been rated up from a Hold to a Buy and the price target has been revised to $55. Analysts at H.C. Wainwright upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late June. As of July 26, 2022, Wedbush has initiated its “an Outperform” rating for VOR. Earlier on April 27, 2022, Goldman initiated its rating. Their recommendation was “a Neutral” for VOR stock.
Analyzing VOR Stock Performance
On last trading session, Vor Biopharma Inc [NASDAQ: VOR] rose 10.90% to $34.69. The stock’s lowest price that day was $31.71, but it reached a high of $36.69 in the same session. During the last five days, there has been a surge of approximately 14.11%. Over the course of the year, Vor Biopharma Inc shares have jumped approximately 92.72%. Shares of the company reached a 52-week high of $65.80 on 07/08/25 and a 52-week low of $2.62 on 05/09/25.
Support And Resistance Levels for Vor Biopharma Inc (VOR)
According to the 24-hour chart, there is a support level at 32.04, which, if violated, would cause prices to drop to 29.38. In the upper region, resistance lies at 37.02. The next price resistance is at 39.34. RSI (Relative Strength Index) is 48.41 on the 14-day chart, showing neutral technical sentiment.
Is Vor Biopharma Inc subject to short interest?
Stocks of Vor Biopharma Inc saw a sharp rise in short interest on 2025-08-29 jumping by 60623.0 shares to 0.99 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 0.93 million shares. A jump of 6.13% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.26 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.26.
Which companies own the most shares of Vor Biopharma Inc (VOR)?
In terms of Vor Biopharma Inc share price expectations, FactSet research, analysts set an average price target of 29 in the next 12 months, down nearly -7.29% from the previous closing price of $31.28. Analysts anticipate Vor Biopharma Inc stock to reach 55 by 2025, with the lowest price target being 3. In spite of this, 2 analysts ranked Vor Biopharma Inc stock as Buy at the end of 2025. On December 17, 2021, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $26.
